Stock Price
9.79
Daily Change
-0.73 -6.98%
Monthly
-27.75%
Yearly
-50.95%
Q1 Forecast
10.19



Peers Price Chg Day Year Date
Amplifon 9.79 -0.73 -6.98% -50.95% Mar/16
Avanos Medical 13.69 0.26 1.94% -5.33% Mar/13
Brookdale Senior Living 13.94 0.04 0.29% 129.28% Mar/13
Cencora 349.95 -2.70 -0.77% 35.60% Mar/13
Diasorin 63.46 -0.54 -0.84% -33.31% Mar/16
Encompass Health 100.37 0.07 0.07% 4.57% Mar/13
Enovis 22.99 -0.40 -1.71% -37.95% Mar/13
GE HealthCare Technologies 70.77 0.44 0.63% -13.66% Mar/13
Pediatrix Medical Group 19.56 0.10 0.51% -8.90% Mar/13
Veradigm 4.84 0.34 7.56% -7.81% Mar/13

Indexes Price Day Year Date
IT40 43957 -359.63 -0.81% 12.65% Mar/16
EU600 594 -1.49 -0.25% 7.88% Mar/16

Amplifon traded at 10.52 this Friday March 13th, increasing 0.13 or 1.20 percent since the previous trading session. Looking back, over the last four weeks, Amplifon gained 22.28 percent. Over the last 12 months, its price fell by 47.33 percent. Looking ahead, we forecast Amplifon to be priced at 10.19 by the end of this quarter and at 9.27 in one year, according to Trading Economics global macro models projections and analysts expectations.

Amplifon SpA is an Italy-based company active in the hearing care retail market. The Company provides personalized solutions and customer care to hearing-impaired people. It offers a wide range of services from diagnosing hearing difficulties, to fitting, servicing and maintaining hearing aids. The Company is organized in three geographical operating segments: Europe, Middle East and Africa - EMEA - (Italy, France, The Netherlands, Germany, the United Kingdom, Ireland, Spain, Portugal, Switzerland, Belgium, Luxemburg, Hungary, Egypt, Turkey, Poland and Israel), Americas (USA, Canada, Chile, Argentina, Ecuador, Colombia, Panama and Mexico) and Asia-Pacific (Australia, New Zealand, India and China).